“Although the past two decades have produced a great deal of progress in neurobiological investigations, the field has thus far failed to identify a single neurobiological phenotypic marker or gene that is useful in making a diagnosis of a major psychiatric disorder or for predicting response to psychopharmacological treatment.”

Does this quote come from another ranting anti-psychiatry activist?

Or perhaps a disgruntled psychiatric survivor with a grudge?

No, this quote comes from the Michael B. First, M.D., a Director/Editor of the research agenda for DSM-V, the Diagnostic and Statistical Manual published by the American Psychiatric Association (APA).

You can find it in the following online document:

A Research Agenda for DSM-V: Summary of the DSM-V Preplanning White Papers Published in May 2002

Source: http://dsm5.org/whitepapers.cfm

And he says it again in a book published by the APA in 2005:

“A Research Agenda for DSM-V”

Edited by David J. Kupfer, M.D., Michael B. First, M.D., and Darrel A. Regier, M.D., M.P.H.

Published by the American Psychiatric Association, Washington, D.C. Available online for free, as a 332 page pdf document, at:

http://appi.org/book.cfm?id=2292

“At the risk of making an overly broad statement of the status of neurobiological investigations of the major psychiatric disorders noted above, it can be concluded that the field of psychiatry has thus far failed to identify a single neurobiological phenotypic marker or gene that is useful in making a diagnosis of a major psychiatric disorder or for predicting response to psychopharmacologic treatment.” (p 33)